Research Articles
The Spirocycle Puzzle: How a Simple Chemical Structure is Revolutionizing Drug Discovery
Discover how spirocyclic molecules and cyclic β-diketones are transforming pharmaceutical development through unique 3D structures.
How AI Designs Cancer Drugs by Reading Cellular Fingerprints
Discover how PaccMann AI is revolutionizing cancer drug discovery by designing treatments based on cellular fingerprints through reinforcement learning.
Unlocking Nature's Medicine Cabinet: The Art of Building Bioactive Molecules
Explore how modern organic synthesis enables scientists to engineer complex bioactive compounds, revolutionizing drug discovery and pharmaceutical development.
The Unsung Hero of Medicine: How a Tiny Molecule is Revolutionizing Drug Discovery
Discover how benzimidazole, a versatile molecular scaffold, is transforming drug discovery for cancer, infections, and more.
Natural Cyclic Peptides: Nature's Blueprint for Next-Generation Medicines
Explore the revolutionary potential of natural cyclic peptides as clinical therapeutics and future medicines bridging small molecules and biologics.
Finding the Needle in the Haystack: Why High-Throughput Screening Is Good for Your Health
Discover how high-throughput screening revolutionizes drug discovery and improves healthcare outcomes through automated testing of millions of compounds.
Unveiling a Molecular Masterpiece: How Computational Chemistry Is Designing Future Medicines
Explore how Density Functional Theory (DFT) and molecular docking are revolutionizing drug discovery through computational analysis of compound BPCLPO.
The Hidden Pharmacy: How Aquatic Plants Are Revolutionizing Drug Discovery
Exploring the untapped potential of aquatic plants in natural products and drug discovery, including bioactive compounds and research methodologies.
BRIDGE: Democratizing the Future of Drug Discovery
BRIDGE is transforming drug discovery by making powerful molecular simulations accessible, reproducible, and shareable to scientists worldwide.
Stopping Cancer in Its Tracks: The Hunt for RON Receptor Inhibitors
Exploring the computational discovery of RON receptor tyrosine kinase inhibitors as promising targeted cancer therapies